Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets

References

• Dearnaley DP, Sydes MR, Graham JD, Aird EG, Bottomley D, Cowan RA, . Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial. Lancet Oncol 2007;8:475–87.
   PubMed Web of Science ®Google Scholar
• Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, . Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 2005;61:1019–34.
   PubMed Web of Science ®Google Scholar
• Coen JJ, Bae K, Zietman AL, Patel B, Shipley WU, Slater JD, . Acute and late toxicity after dose escalation to 82 GyE using conformal proton radiation for localized prostate cancer: Initial report of American College of Radiology Phase II study 03-12. Int J Radiat Oncol Biol Phys 2011;81:1005–9.
   PubMed Web of Science ®Google Scholar
• Coen JJ, Paly JJ, Niemierko A, Weyman E, Rodrigues A, Shipley WU, . Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2012;82:201–9.
   Google Scholar
• Olsen DR, Bruland OS, Frykholm G, Norderhaug IN. Proton therapy – a systematic review of clinical effectiveness. Radiother Oncol 2007;83:123–32.
   PubMed Web of Science ®Google Scholar
• Nyström H, Blomqvist E, Høyer M, Montelius A, Muren LP, Nilsson P, . Particle therapy – a next logical step in the improvement of radiotherapy. Acta Oncol 2011;50:741–4.
   PubMed Web of Science ®Google Scholar
• Vargas C, Wagner M, Mahajan C, Indelicato D, Fryer A, Falchook A, . Proton therapy coverage for prostate cancer treatment. Int J Radiat Oncol Biol Phys 2008; 70:1492–501.
   PubMed Web of Science ®Google Scholar
• Zietman AL, Bae K, Slater JD, Shipley WU, Efstathiou JA, Coen JJ, . Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group/American College Of Radiology 95-09. J Clin Oncol 2010;28: 1106–11.
   PubMed Web of Science ®Google Scholar
• Wang D, Lawton C. Pelvic lymph node irradiation for prostate cancer: Who, why, and when. Semin Radiat Oncol 2008;18:35–40.
   PubMed Web of Science ®Google Scholar
• Widesott L, Pierelli A, Fiorino C, Lomax AJ, Amichetti M, Cozzarini C, . Helical tomotherapy versus intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: Dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis. Int J Radiat Oncol Biol Phys 2011;80:1589–600.
   PubMed Web of Science ®Google Scholar
• Lassen-Ramshad Y, Vestergaard A, Muren LP, Høyer M, Petersen JB. Plan robustness in proton beam therapy of a childhood brain tumour. Acta Oncol 2011;50:791–6.
   PubMed Web of Science ®Google Scholar
• Johansson B, Ridderheim M, Glimelius B. The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers. Acta Oncol 2005;44:890–5.
   PubMed Web of Science ®Google Scholar
• Allen AM, Pawlicki T, Dong L, Fourkal E, Buyyounouski M, Cengel K, . An evidence based review of proton beam therapy: The report of ASTRO’s emerging technology committee. Radiother Oncol 2012;103:8–11.
   PubMed Web of Science ®Google Scholar
• Chera BS, Vargas C, Morris CG, Louis D, Flampouri S, Yeung D, . Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2009;75:994–1002.
   PubMed Web of Science ®Google Scholar
• Schippers JM, Lomax AJ. Emerging technologies in proton therapy. Acta Oncol 2011;50:838–50.
   PubMed Web of Science ®Google Scholar
• Liang J, Wu Q, Yan D. The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2009; 73:935–43.
   PubMed Web of Science ®Google Scholar
• Thörnqvist S, Bentzen L, Petersen JB, Hysing LB, Muren LP. Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques. Acta Oncol 2011; 50:926–34.
   PubMed Web of Science ®Google Scholar
• Thörnqvist S, Petersen JB, Høyer M, Bentzen L, Muren LP. Propagation of target and organ at risk contours in radiotherapy of prostate cancer using deformable image registration. Acta Oncol 2010;49:1023–32.
   PubMed Web of Science ®Google Scholar
• Lomax A, Pedroni E, Schaffner B, Scheib S, Schneider U, Tourovsky A. 3D treatment planning for conformal proton therapy by spotscanning. In: Faulkner K, Carey B, Crellin A, Harrison RM, editors. Quantitative imaging in oncology. London: BIR Publishing; 1996. p. 67–71.
   Google Scholar
• International Commission on Radiation Units and Measurements. Prescribing, recording and reporting proton-beam therapy (ICRU Report 78). J ICRU 2007;7.
   Google Scholar
• Andersen ES, Muren LP, Sørensen TS, Noe KO, Thor M, Petersen JB, . Bladder dose accumulation based on a biomechanical deformable image registration algorithm in volumetric modulated arc therapy for prostate cancer. Phys Med Biol 2012;57:7089–100.
   PubMed Web of Science ®Google Scholar
• Niemierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 1997;24: 103–10.
   PubMed Web of Science ®Google Scholar
• Niemierko A. A generalized concept of equivalent uniform dose. Med Phys 1999;26:1000 (Abstract).
   Google Scholar
• Søvik Å, Ovrum J, Olsen DR, Malinen E. On the parameter describing the generalised equivalent uniform dose (gEUD) for tumours. Phys Med 2002;23:100–6.
   Web of Science ®Google Scholar
• Zhang X, Dong L, Lee AK, Cox JD, Kuban DA, Zhu RX, . Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment. Int J Radiat Oncol Biol Phys 2007;67:620–9.
   PubMed Web of Science ®Google Scholar
• Soukup M, Söhn M, Yan D, Liang J, Alber M. Study of robustness of IMPT and IMRT for prostate cancer against organ movement. Int J Radiat Oncol Biol Phys 2009;75: 941–9.
   PubMed Web of Science ®Google Scholar
• Smeenk RJ, Teh BS, Butler EB, van Lin EN, Kaanders JH. Is there a role for endorectal balloons in prostate radiotherapy?A systematic review. Radiother Oncol 2010;95: 277–82.
   PubMed Web of Science ®Google Scholar
• Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: The potential effects of inter-fraction and inter-field motions. Phys Med Biol 2008; 53:1043–56.
   PubMed Web of Science ®Google Scholar
• Park PC, Zhu XR, Lee AK, Sahoo N, Melancon AD, Zhang L, . A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties. Int J Radiat Oncol Biol Phys 2012; 82:329–36.
   PubMedGoogle Scholar
• De Ruysscher D, Mark Lodge M, Jones B, Brada M, Munro A, Jefferson T, . Charged particles in radiotherapy: A 5-year update of a systematic review. Radiother Oncol 2012;103:5–7.
   PubMed Web of Science ®Google Scholar
• Nihei K, Ogino T, Onozawa M, Murayama S, Fuji H, Murakami M, . Multi-institutional phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities. Int J Radiat Oncol Biol Phys 2011;81:390–6.
   PubMed Web of Science ®Google Scholar
• Trofimov A, Nguyen PL, Efstathiou JA, Wang Y, Lu HM, Engelsman M, . Interfractional variations in the setup of pelvic bony anatomy and soft tissue, and their implications on the delivery of proton therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2011;80:928–37.
   PubMed Web of Science ®Google Scholar
• Stuschke M, Kaiser A, Pöttgen C, Lübcke W, Farr J. Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans. Radiother Oncol 2012;104:45–51.
   PubMed Web of Science ®Google Scholar